Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
GSK
GSK
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
GSK News
First Oral Carbapenem Antibiotic Approved in the US
2d ago
Globenewswire
First Oral Carbapenem Antibiotic Approved in the US
2d ago
Newsfilter
First Oral Carbapenem Antibiotic Approved in the US
2d ago
Newsfilter
GSK and Spero's Utebzi Approved by FDA for UTIs
2d ago
seekingalpha
Gilead's HIV Prevention Drug Filing Accepted by FDA
2d ago
NASDAQ.COM
Biotech IPO Market Reopens Amid M&A Surge
4d ago
CNBC
Biotech Investors Become More Selective Amid Market Changes
4d ago
Newsfilter
Investigation Alerts for Multiple Mergers
4d ago
Globenewswire
Global Market Sentiment Affected by Energy Prices
5d ago
seekingalpha
Biotech Sector Sees Surge in FDA and Global Approvals
Jun 12 2026
NASDAQ.COM
GSK Receives Orphan Drug Designation for VEXAS Syndrome Treatment
Jun 12 2026
NASDAQ.COM
UK Tech Ecosystem Rebounds with New Growth
Jun 10 2026
CNBC
Tech Stocks Retreat as DraftKings Soars on SEC Filing
Jun 09 2026
CNBC
Investor Alert: Investigations into Multiple Mergers
Jun 09 2026
Globenewswire
New Advances in Cancer Treatment in Biotechnology
Jun 09 2026
Newsfilter
SpaceX IPO Heats Up Amid Market Recovery
Jun 09 2026
CNBC
Show More News
